Advertisement

Topics

New Blood Test Opens Door to Precision Medicine for Prostate Cancer

05:55 EDT 21 Jun 2017 | PharmPro

New three-in-one blood test opens door to precision medicine for prostate cancer. Researchers found they could pick out which men with advanced prostate cancer were likely to benefit from treatment with new drugs called PARP inhibitors.
Contributed Author: 
Institute of Cancer Research

Original Article: New Blood Test Opens Door to Precision Medicine for Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "New Blood Test Opens Door to Precision Medicine for Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...